These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29165196)

  • 21. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma.
    Iikura Y; Uchiyama H; Akimoto K; Ebisawa M; Sakaguchi N; Tsubaki T; Ishizu H; Kabayama H; Yagi K; Miura K
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):147-51. PubMed ID: 7697473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
    Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
    Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formoterol, 24 microg bid, and serious asthma exacerbations: similar rates compared with formoterol, 12 microg bid, with and without extra doses taken on demand, and placebo.
    Wolfe J; Laforce C; Friedman B; Sokol W; Till D; Della Cioppa G; van As A
    Chest; 2006 Jan; 129(1):27-38. PubMed ID: 16424410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.
    Grimfeld A; Holgate ST; Canonica GW; Bonini S; Borres MP; Adam D; Canseco Gonzalez C; Lobaton P; Patel P; Szczeklik A; Danzig MR; Roman I; Bismut H; Czarlewski W
    Clin Exp Allergy; 2004 Nov; 34(11):1665-72. PubMed ID: 15544588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE
    N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.
    Ducharme FM; Lemire C; Noya FJ; Davis GM; Alos N; Leblond H; Savdie C; Collet JP; Khomenko L; Rivard G; Platt RW
    N Engl J Med; 2009 Jan; 360(4):339-53. PubMed ID: 19164187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Addition of Inhaled Budesonide to Standard Therapy Shortens the Length of Stay in Hospital for Asthmatic Preschool Children: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razi CH; Akelma AZ; Harmanci K; Kocak M; Kuras Can Y
    Int Arch Allergy Immunol; 2015; 166(4):297-303. PubMed ID: 26044872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
    Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
    Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
    Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of nedocromil sodium on childhood asthma during the viral season.
    König P; Eigen H; Ellis MH; Ellis E; Blake K; Geller D; Shapiro G; Welch M; Scott C
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1879-86. PubMed ID: 8520750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
    Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
    PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
    Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
    Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
    Pauwels RA; Pedersen S; Busse WW; Tan WC; Chen YZ; Ohlsson SV; Ullman A; Lamm CJ; O'Byrne PM;
    Lancet; 2003 Mar; 361(9363):1071-6. PubMed ID: 12672309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma.
    Barnes N; Pavord I; Chuchalin A; Bell J; Hunter M; Lewis T; Parker D; Payton M; Collins LP; Pettipher R; Steiner J; Perkins CM
    Clin Exp Allergy; 2012 Jan; 42(1):38-48. PubMed ID: 21762224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.